Back to results
US 2025/0367153 A1Published application
Composition and application thereof
AssigneeSyneuRx International (Taiwan) Corp.
InventorsGuo-Chuan TSAI, Wei-Hua CHANG, Lu-Ping LU, Chi-Sheng KUO, Xiao-Yi ZHUANG
Life of this patent
Estimating the term…
Abstract
A composition, comprising a D-amino acid oxidase (DAAO) inhibitor and a N-methyl-D-aspartate (NMDA) modulator. Also provided herein are the method of the uses of by administering to a subject in need thereof an effective amount of the composition.
Claims20
A composition, comprising:
- a D-amino acid oxidase (DAAO) inhibitor;
- and
- a N-methyl-D-aspartate (NMDA) modulator.
Dependencies are inferred from the claim text.